Stockreport

vTv Therapeutics completes Phase 1b study evaluating TTP399 for the treatment of T1D [Seeking Alpha]

vTv Therapeutics Inc. - Class A  (VTVT) 
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vtvtherapeutics.com
PDF vTv Therapeutics completes Phase 1b study evaluating TTP399 for the treatment of T1DvTv Therapeutics (NASDAQ:VTVT)announces the completion of Phase 1b clinical trial, Si [Read more]